Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|February 14, 1998
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapyF S van Dam, S B Schagen, M J Muller, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II studyG Stoter, E Shiloni, S Aamdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatinA D R Huitema, M Spaander, R A A Mathĵt, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patientsS B Schagen, M J Muller, W Boogerd, et al.
The American Journal of Surgical Pathology|March 1, 1993
Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smokingW H Westra, G J Offerhaus, S N Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionL J van Warmerdam, W W ten Bokkel Huinink, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancerS Rodenhuis, A Westermann, M J Holtkamp, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibodyA Hekman, A Honselaar, W M Vuist, et al.
Breast Cancer Research and Treatment|July 6, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy responseE H Lips, L Mulder, J J de Ronde, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|February 14, 1998
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapyF S van Dam, S B Schagen, M J Muller, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II studyG Stoter, E Shiloni, S Aamdal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatinA D R Huitema, M Spaander, R A A Mathĵt, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patientsS B Schagen, M J Muller, W Boogerd, et al.
The American Journal of Surgical Pathology|March 1, 1993
Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smokingW H Westra, G J Offerhaus, S N Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusionL J van Warmerdam, W W ten Bokkel Huinink, S Rodenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancerS Rodenhuis, A Westermann, M J Holtkamp, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibodyA Hekman, A Honselaar, W M Vuist, et al.
Breast Cancer Research and Treatment|July 6, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy responseE H Lips, L Mulder, J J de Ronde, et al.
Pageof 15